Chief Legal Officer and Corporate Secretary · X4 Pharmaceuticals, Inc (XFOR)

Derek Meisner

A named executive officer of X4 Pharmaceuticals in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,039,269

Salary $428,173Stock awards $415,234

FY2020: $1,113,364

3rd of 3 named executive officers at X4 Pharmaceuticals by FY2021 total.

3 named officers on file for X4 Pharmaceuticals, FY2021

Derek Meisner’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how X4 Pharmaceuticals’s whole pay program stands against its peers

  • X4 Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on XFOR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2022 (DEF 14A).

Free

Get Derek Meisner’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Derek Meisner compensation by year

X4 Pharmaceuticals Summary Compensation Table · all 2 fiscal years held
In US dollars, as X4 Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$400,000$428,173
Bonus$67,500$0
Stock awards$471,500$415,234
Option awards$0$0
Non-equity incentive$162,400$184,338
Pension and deferred compensation$0$0
All other$11,964$11,524
Total$1,113,364$1,039,269

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: X4 Pharmaceuticals, Inc DEF 14A filed April 25, 2022, accession 0001628280-22-010145, and prior-year filings.

How this page was built: the X4 Pharmaceuticals, Inc filed document, accession 0001628280-22-010145. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2022.

$1.1M
$1.0M
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
PSU47,728$109,297—
PSU25,000$57,250—
Option25,208—$11.03

Per the Outstanding Equity Awards at Fiscal Year-End table in X4 Pharmaceuticals, Inc's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

X4 Pharmaceuticals’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Paula RaganPresident and Chief Executive Officer$2,141,328
Adam MostafaChief Financial Officer and Treasurer$1,338,931
Derek Meisner · this pageChief Legal Officer and Corporate Secretary$1,039,269

The full X4 Pharmaceuticals compensation record

free company brief

This page is one person within X4 Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are X4 Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Derek Meisner's compensation dossier · One-time report. No refunds.